Home>Topics>Drug Companies

Drug Companies

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. UPDATE 1-Actavis, Adamas win FDA approval for Alzheimer's drug

    Headlines

    Wed, 24 Dec 2014

    Dec 24 (Reuters) - The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis Plc and Adamas Pharmaceuticals Inc.

  2. Actavis, Adamas win FDA approval for Alzheimer's drug

    Headlines

    Wed, 24 Dec 2014

    Dec 24 (Reuters) - The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis Plc and Adamas Pharmaceuticals Inc.

  3. Exclusive: Express Scripts presses for more drug savings with coverage list

    Headlines

    Tue, 23 Dec 2014

    largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year.

  4. UPDATE 1-BioCryst's Ebola drug shows promise in animal study

    Headlines

    Tue, 23 Dec 2014

    Dec 23 (Reuters) - BioCryst Pharmaceuticals Inc said its experimental broad-spectrum antiviral drug showed promise against Ebola when tested in monkeys.

  5. UPDATE 1-U.S. regulator charges two Chileans with insider trading

    Headlines

    Mon, 22 Dec 2014

    NEW YORK/SANTIAGO (Reuters) - A former board member of Chile's CFR Pharmaceuticals SA was charged on Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories' $2.9...

  6. U.S. regulator charges two with insider trading in Abbott deal

    Headlines

    Mon, 22 Dec 2014

    NEW YORK/SANTIAGO, Dec 22 (Reuters) - A former board member of Chile's CFR Pharmaceuticals SA was charged Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories' $2.9 billion acquisition of CFR earlier this year.

  7. UPDATE 2-FDA approves BioCryst's intravenous flu drug

    Headlines

    Mon, 22 Dec 2014

    Dec 22 (Reuters) - The U.S. Food and Drug Administration approved BioCryst Pharmaceuticals Inc's single-dose flu drug, in what the company says is the agency's first ever approval for an intravenous...

  8. Tekmira to supply Ebola treatment for studies in West Africa

    Headlines

    Mon, 22 Dec 2014

    TORONTO, Dec 22 (Reuters) - Tekmira Pharmaceuticals Corp will supply one of its experimental Ebola treatments for clinical studies to be conducted in West Africa by a consortium that includes England's Oxford university, the Canadian company said on Monday.

  9. Achillion shares soar as potential treatment seen as hep C cure

    Headlines

    Mon, 22 Dec 2014

    Dec 22 (Reuters) - Achillion Pharmaceuticals Inc said it would test a combination of two of its experimental hepatitis C drugs after they showed promise against the virus in separate studies.

  10. FDA approves BioCryst's flu shot

    Headlines

    Mon, 22 Dec 2014

    Dec 22 (Reuters) - The U.S. Food and Drug Administration approved Biocryst Pharmaceuticals Inc's single-dose flu shot on Monday, for use in adults with acute uncomplicated influenza.

« Prev12345Next »
Content Partners